Tag: 上海419论坛WM


Human knockouts may reveal why some drugs fail


first_img Human ‘knockouts’ may reveal why some drugs fail Email Babar Shah/PPI Images/Newscom By Jocelyn KaiserApr. 12, 2017 , 1:00 PM When scientists want to figure out what a specific gene does in mice, they knock it out. That can’t be done with humans, but some people are natural knockouts—born missing one or more genes. Now, a look at the DNA of 10,500 Pakistanis has found more than 1300 genes that are knocked out without causing obvious medical issues. The results may help confirm why a new heart disease drug flopped in clinical trials, and why another new drug should work just fine.The study is the latest of several hunts for apparently healthy human knockouts that have included Iceland and the United Kingdom. “The Human Genome Project gave us a parts list of 18,000 genes, and this project is trying to understand what missing a part means in terms of biological consequences,” says heart disease geneticist Sekar Kathiresan of the Broad Institute in Cambridge, Massachusetts, who co-led the study.In Pakistan, people often marry their first cousins. That raises the odds that a mother and father will both pass identical copies of a mutation in a specific gene to their children. (Unless the mutated gene is on a sex chromosome, both parental copies of a gene have to be disabled for a full knockout.) Kathiresan’s group sequenced the DNA of 10,503 Pakistanis who are participating in a long-term heart disease and diabetes study and found 1317 fully knocked-out genes. The team then looked for abnormalities in about 200 clinical blood biomarkers such as cholesterol. Sign up for our daily newsletter Get more great content like this delivered right to you! Countrycenter_img A genetics study in Pakistan has turned up 1300 genes that humans can live without.  Click to view the privacy policy. Required fields are indicated by an asterisk (*) Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Seven genes were disabled in at least two people and clearly matched up with some biomarker change, such as unusually low insulin levels, the team reports today in Nature. One codes for an enzyme called Lp-PLA2 that has been linked to arterial plaque. Because higher blood levels of Lp-PLA2 correlate with more heart attacks, drug companies have already spent billions of dollars on Lp-PLA2–blocking drugs. But Pakistanis who lacked one or both copies of the gene didn’t have a lower risk of heart disease, which adds to other genetics studies that may explain why these drugs failed in the clinic.On the other hand, the study found strong support for another heart disease drug target, a protein called ApoC-III that limits the body’s ability to metabolize fats called triglycerides. Although Kathiresan’s team has studied people missing one copy of the APCO3 gene, “we’ve been looking for the past 4 years for humans who completely lack it.” They had found none in the United States and Europe, he says, but in Pakistan, his group identified a whole family where both parents and all nine of their children lack the APCO3 gene.When the family members drank a fat-laden milkshake, their blood fat levels barely rose, suggesting they have little artery-clogging fat in their bodies and should be protected against heart attacks. The family also seemed perfectly healthy, so ApoC-III–blocking drugs now in clinical testing should be safe, Kathiresan predicts. The drugs could eventually join another heart disease–preventing drug that came out of the discovery of a healthy woman missing a gene called PCSK9.The Pakistani study is the first in which researchers tested some of the knockouts they had found to learn more about their health, says human geneticist David Van Heel of Queen Mary University of London, who last year published a smaller knockout study of British-Pakistanis. Because these individuals are so rare, “we really all need to keep going to sequence more and more people,” he says. About 200,000 Pakistanis would be enough to find knockouts of about 8700 genes, Kathiresan’s team estimates. (Some of these genes are essential to early development, however, so a human knockout would never be born.)Kathiresan and others is now calling for a Human Knockout Project that would pool all the data coming out of these projects and other large population genetics studies in a single database. Co-author Daniel MacArthur of the Broad Institute will soon release a prototype containing knocked-out genes from a larger collection of human genomes called ExAC. Eventually the plan is to make it possible for academic researchers—and drug companies—to reach out to the leaders of the original study so they can contact an individual knockout from the database and bring the person into a clinic for more testing.last_img read more




Recent Comments